AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 61(1), 1999, pp. 163-170
Copyright © 1999 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarr, P.
Right arrow Articles by Heymann, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarr, P.
Right arrow Articles by Heymann, D.
Related Collections
Right arrow Typhoid Fever
Right arrow Epidemiology
American Journal of Tropical Medicine and Hygiene, Vol 61, Issue 1, 163-170
Copyright © 1999 by American Society of Tropical Medicine and Hygiene

Research Articles


Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan

PE Tarr, L Kuppens, TC Jones, B Ivanoff, PG Aparin, and DL Heymann

We report on the ongoing epidemic of typhoid fever in Tajikistan that started in 1996. It has involved more than 24,000 cases to date, and is characterized by multiple point sources, overflow of sewage, contaminated municipal water, and person-to-person spread. Of the Salmonella typhi isolates available for testing in western laboratories, more than 90% are multidrug-resistant (MDR). Most recently, 28 (82%) of 34 isolates are resistant to ciprofloxacin, representing the first reported epidemic of quinolone-resistant typhoid fever. In the past, mass immunization during typhoid fever epidemics has been discouraged. A review of this policy is recommended in light of the alarming emergence of quinolone-resistant strains of S. typhi, the availability of improved vaccines, and the ongoing epidemic in Tajikistan. Mass immunization may be a useful measure for the control of prolonged MDR typhoid fever epidemics, as an adjunct to correction of municipal infrastructure and public health intervention.


This article has been cited by other articles:


Home page
 NEJMHome page
C. M. Parry, T. T. Hien, G. Dougan, N. J. White, and J. J. Farrar
Typhoid Fever
N. Engl. J. Med., November 28, 2002; 347(22): 1770 - 1782.
[Full Text] [PDF]

Home page
 NEJMHome page
F. Y. C. Lin, V. A. Ho, H. B. Khiem, D. D. Trach, P. V. Bay, T. C. Thanh, Z. Kossaczka, D. A. Bryla, J. Shiloach, J. B. Robbins, et al.
The Efficacy of a Salmonella typhi Vi Conjugate Vaccine in Two-to-Five-Year-Old Children
N. Engl. J. Med., April 26, 2001; 344(17): 1263 - 1269.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. L. Guerrant and M. Kosek
Polysaccharide Conjugate Typhoid Vaccine
N. Engl. J. Med., April 26, 2001; 344(17): 1322 - 1323.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society of Tropical Medicine and Hygiene.